Cart
sales@molnova.com
Autogramin-1
CAS No. 2375541-73-2
Autogramin-1( —— )
Catalog No. M26065 CAS No. 2375541-73-2
Autogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 528 | In Stock |
|
| 10MG | 755 | In Stock |
|
| 25MG | 1152 | In Stock |
|
| 50MG | 1548 | In Stock |
|
| 100MG | 2088 | In Stock |
|
| 500MG | 4185 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAutogramin-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionAutogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM.
-
DescriptionAutogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM. Autogramin-1 also inhibits Rapamycin (mTORC1)-induced autophagy with IC50 of 0.44 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptorP2X3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2375541-73-2
-
Formula Weight485.56
-
Molecular FormulaC23H27N5O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 6.94 mg/mL (14.29 mM)
-
SMILESCCCn1c(=O)[nH]c2cc(ccc2c1=O)C(=O)Nc1nc2CCN(Cc2s1)C(=O)OC(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Spinaci A, et, al. P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications. Front Pharmacol. 2021 Apr 13;12:653561.
molnova catalog
related products
-
DMH-25
DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology.
-
FT-1518
FT-1518 is an orally available, selective and potent mTORC1 and mTORC2 inhibitor with anticancer and antitumor activity for cancer research.
-
MHY-1685
MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.
